- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1476-5470
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Macrophage-mediated anti-tumor immunity against high-risk neuroblastoma ; volume:23 ; number:3-4 ; day:7 ; month:5 ; year:2022 ; pages:129-140 ; date:6.2022
Genes and immunity ; 23, Heft 3-4 (7.5.2022), 129-140, 6.2022
- Creator
-
Tang, Xao X.
Shimada, Hiroyuki
Ikegaki, Naohiko
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41435-022-00172-w
- URN
-
urn:nbn:de:101:1-2022081723194441447755
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:34 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Tang, Xao X.
- Shimada, Hiroyuki
- Ikegaki, Naohiko
- SpringerLink (Online service)
Other Objects (12)
Artificial Macrophage with Hierarchical Nanostructure for Biomimetic Reconstruction of Antitumor Immunity
Cryo-thermal therapy induces macrophage polarization for durable anti-tumor immunity
Depletion of slow-cycling PDGFRα+ADAM12+ mesenchymal cells promotes antitumor immunity by restricting macrophage efferocytosis
TH9 cells in anti-tumor immunity
Anlotinib Combined with Anti‐PD1 Potentiates Anti‐Tumor Immunity via Immunogenic Cell Death and Macrophage Reprogramming
Cytokine-induced killer cells promote antitumor immunity
Induction of antitumor immunity through xenoplacental immunization
Combined mitoxantrone and anti-TGFβ treatment with PD-1 blockade enhances antitumor immunity by remodelling the tumor immune landscape in neuroblastoma
Necroptosis stimulates interferon-mediated protective anti-tumor immunity
Tumor immune microenvironment (TIME) to enhance antitumor immunity
Integrin CD11b activation drives anti-tumor innate immunity
Novel therapeutic strategies targeting telomere maintenance mechanisms in high-risk neuroblastoma
Artificial Macrophage with Hierarchical Nanostructure for Biomimetic Reconstruction of Antitumor Immunity
Cryo-thermal therapy induces macrophage polarization for durable anti-tumor immunity
Depletion of slow-cycling PDGFRα+ADAM12+ mesenchymal cells promotes antitumor immunity by restricting macrophage efferocytosis
TH9 cells in anti-tumor immunity
Anlotinib Combined with Anti‐PD1 Potentiates Anti‐Tumor Immunity via Immunogenic Cell Death and Macrophage Reprogramming
Cytokine-induced killer cells promote antitumor immunity
Induction of antitumor immunity through xenoplacental immunization
Combined mitoxantrone and anti-TGFβ treatment with PD-1 blockade enhances antitumor immunity by remodelling the tumor immune landscape in neuroblastoma
Necroptosis stimulates interferon-mediated protective anti-tumor immunity
Tumor immune microenvironment (TIME) to enhance antitumor immunity
Integrin CD11b activation drives anti-tumor innate immunity
Novel therapeutic strategies targeting telomere maintenance mechanisms in high-risk neuroblastoma
Artificial Macrophage with Hierarchical Nanostructure for Biomimetic Reconstruction of Antitumor Immunity
Cryo-thermal therapy induces macrophage polarization for durable anti-tumor immunity
Depletion of slow-cycling PDGFRα+ADAM12+ mesenchymal cells promotes antitumor immunity by restricting macrophage efferocytosis
TH9 cells in anti-tumor immunity
Anlotinib Combined with Anti‐PD1 Potentiates Anti‐Tumor Immunity via Immunogenic Cell Death and Macrophage Reprogramming
Cytokine-induced killer cells promote antitumor immunity
Induction of antitumor immunity through xenoplacental immunization
Combined mitoxantrone and anti-TGFβ treatment with PD-1 blockade enhances antitumor immunity by remodelling the tumor immune landscape in neuroblastoma
Necroptosis stimulates interferon-mediated protective anti-tumor immunity
Tumor immune microenvironment (TIME) to enhance antitumor immunity
Integrin CD11b activation drives anti-tumor innate immunity